ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 241 filers reported holding ARRAY BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $282,000 | +73.0% | 11,553 | +0.9% | 0.29% | +33.6% |
| Q4 2018 | $163,000 | -6.3% | 11,448 | +0.0% | 0.22% | +35.8% |
| Q3 2018 | $174,000 | -57.1% | 11,447 | -52.7% | 0.16% | -53.4% |
| Q2 2018 | $406,000 | +88.0% | 24,214 | +82.9% | 0.35% | +68.1% |
| Q1 2018 | $216,000 | +21500.0% | 13,236 | +18283.3% | 0.21% | +20600.0% |
| Q4 2017 | $1,000 | 0.0% | 72 | -49.3% | 0.00% | 0.0% |
| Q1 2017 | $1,000 | 0.0% | 142 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,000 | -95.5% | 142 | -97.1% | 0.00% | -92.3% |
| Q2 2013 | $22,000 | – | 4,837 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |